Diabetologia

EASD News Section July 2004
pp. R65-R66(2)

Does WHI tell us how to prevent diabetes?
pp. 1133-1134(2)
Author: Seaquist, E.

Interleukin-6 and insulin sensitivity: friend or foe?
pp. 1135-1142(8)
Authors: Carey, A.; Febbraio, M.

Towards worldwide standardisation of HbA₁c determination
pp. 1143-1148(6)
Author: Miedema, K.

Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver
pp. 1149-1156(8)
Authors: Iozzo, P.; Lautamaki, R.; Geisler, F.; Virtanen, K.; Oikonen, V.; Haaparanta, M.; Yki-Jarvinen, H.; Ferrannini, E.; Knuuti, J.; Nuutila, P.

Loss of beta cell function as fasting glucose increases in the non-diabetic range
pp. 1157-1166(10)
Authors: Godsland, I.; Jeffs, J.; Johnston, D.

Mutation at position −132 in the islet amyloid polypeptide (IAPP) gene promoter enhances basal transcriptional activity through a new CRE-like binding site
pp. 1167-1174(8)
Authors: Novials, A.; Mato, E.; Lucas, M.; Franco, C.; Rivas, M.; Santisteban, P.; Gomis, R.

Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial
pp. 1175-1187(13)
Authors: Margolis, K.; Bonds, D.; Rodabough, R.; Tinker, L.; Phillips, L.; Allen, C.; Bassford, T.; Burke, G.; Torrens, J.; Howard, B.

Impact of diabetes mellitus on long-term outcome after unstable angina and non-ST-segment elevation myocardial infarction treated with a very early invasive strategy
pp. 1188-1195(8)
Authors: Müller, C.; Neumann, F.; Ferenc, M.; Perruchoud, A.; Büttner, H.

Ultrastructural alterations in capillaries of the diabetic hypertensive rat retina: protective effects of ACE inhibition
pp. 1196-1201(6)
Authors: Dosso, A.; Rungger-Brändle, E.; Leuenberger, P.

Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits
pp. 1202-1209(8)
Authors: Kitajima, S.; Morimoto, M.; Liu, E.; Koike, T.; Higaki, Y.; Taura, Y.; Mamba, K.; Itamoto, K.; Watanabe, T.; Tsutsumi, K.; Yamada, N.; Fan, J.

Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy
pp. 1210-1222(13)
Authors: Adhikary, L.; Chow, F.; Nikolic-Paterson, D.; Stambe, C.; Dowling, J.; Atkins, R.; Tesch, G.

Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats
pp. 1223-1231(9)
Authors: Palm, F.; Hansell, P.; Ronquist, G.; Waldenström, A.; Liss, P.; Carlsson, P.-O.

Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes
pp. 1232-1244(13)
Authors: Anis, Y.; Leshem, O.; Reuveni, H.; Wexler, I.; Ben Sasson, R.; Yahalom, B.; Laster, M.; Raz, I.; Ben Sasson, S.; Shafrir, E.; Ziv, E.

Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies
pp. 1245-1256(12)

Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys
pp. 1257-1265(9)
Authors: Pyörälä, K.; Lehto, S.; Bacquer, D.; Sutter, J.; Sans, S.; Keil, U.; Wood, D.; Backer, G.

Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes—the Linköping Diabetes Complications Study
pp. 1266-1272(7)
Authors: Nordwall, M.; Bojestig, M.; Arnqvist, H.; Ludvigsson, J.

Mutation analysis of suppressor of cytokine signalling 3, a candidate gene in Type 1 diabetes and insulin sensitivity
pp. 1273-1277(5)
Authors: Gylvin, T.; Nolsøe, R.; Hansen, T.; Nielsen, E.; Bergholdt, R.; Karlsen, A.; Billestrup, N.; Borch-Johnsen, K.; Pedersen, O.; Mandrup-Poulsen, T.; Nerup, J.; Pociot, F.

Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects
pp. 1278-1284(7)
Authors: Kipfer-Coudreau, S.; Eberlé, D.; Sahbatou, M.; Bonhomme, A.; Guy-Grand, B.; Froguel, P.; Galan, P.; Basdevant, A.; Clément, K.

T lymphocyte response against pancreatic beta cell antigens in fulminant Type 1 diabetes
pp. 1285-1291(7)
Authors: Kotani, R.; Nagata, M.; Imagawa, A.; Moriyama, H.; Yasuda, H.; Miyagawa, J.; Hanafusa, T.; Yokono, K.

Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cells
pp. 1292-1302(11)
Authors: Souza, K.; Elsner, M.; Mathias, P.; Lenzen, S.; Tiedge, M.

Serum adiponectin levels predict the effect of short-term dietary interventions on insulin sensitivity in humans
pp. 1303-1305(3)
Authors: Thamer, C.; Haap, M.; Bachmann, O.; Nieden, T.; Tschritter, O.; Stefan, N.; Fritsche, A.; Jacob, S.; Stumvoll, M.; Häring, H.

Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin
pp. 1306-1313(8)
Authors: Ye, J.-M.; Dzamko, N.; Cleasby, M.; Hegarty, B.; Furler, S.; Cooney, G.; Kraegen, E.

WY-14643 and 9-cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients
pp. 1314-1323(10)
Authors: Bouzakri, K.; Roques, M.; Debard, C.; Berbe, V.; Rieusset, J.; Laville, M.; Vidal, H.

Simple non-invasive assessment of advanced glycation endproduct accumulation
pp. 1324-1330(7)
Authors: Meerwaldt, R.; Graaff, R.; Oomen, P.; Links, T.; Jager, J.; Alderson, N.; Thorpe, S.; Baynes, J.; Gans, R.; Smit, A.

Neonatal oral administration of DiaPep277, combined with hydrolysed casein diet, protects against Type 1 diabetes in BB-DP rats. An experimental study
pp. 1331-1333(3)
Authors: Brugman, S.; Klatter, F.; Visser, J.; Bos, N.; Elias, D.; Rozing, J.

—to: Hales CN, Ozanne SE (2003) For Debate: Fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure. Diabetologia 46:1013–1019
pp. 1334-1335(2)
Authors: Plagemann, A.; Rodekamp, E.; Harder, T.

Reply to Comment on: Hales CN, Ozanne SE (2003) For Debate: Fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure
pp. 1336-1336(1)
Authors: Hales, C.; Ozanne, S.

Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans
pp. 1337-1338(2)
Authors: Cho, Y.; Youn, B.-S.; Chung, S.; Kim, K.; Lee, H.; Yu, K.-Y.; Park, H.; Shin, H.; Park, K.